The Impact of Fasting Duration on Quality of Recovery After Cesarean Section
Launched by JEWISH GENERAL HOSPITAL · Nov 20, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the length of time a patient fasts before an elective cesarean section (C-section) affects their recovery after the surgery. Specifically, the researchers want to see if fasting for 6 hours without solid food or 2 hours without clear fluids makes a difference in how well patients feel and recover in the first day after their C-section. Patients will be asked to answer 11 questions about their recovery 24 hours after the surgery, and various factors will be monitored to understand their impact on the recovery process.
To participate in this trial, women who are scheduled for an elective C-section under spinal anesthesia may be eligible. However, those who cannot communicate in French or English, need an emergency C-section, or are planned to have general anesthesia will not be included. If you decide to take part, you can expect to share your experience about your recovery after the surgery through a simple questionnaire. This study aims to improve the overall recovery experience for future patients undergoing C-sections.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Presenting for elective c-section under spinal anesthesia
- Exclusion Criteria:
- • Unable to communicate in French or English
- • Urgent c-section
- • Planned general anesthesia
About Jewish General Hospital
The Jewish General Hospital (JGH) is a leading academic health care institution in Montreal, Canada, renowned for its commitment to excellence in patient care, research, and education. As a sponsor of clinical trials, JGH leverages its state-of-the-art facilities and multidisciplinary expertise to advance medical knowledge and improve treatment outcomes across various specialties. The hospital is dedicated to fostering innovation through rigorous scientific investigation and collaboration with renowned research institutions, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. With a focus on patient-centered research, JGH aims to translate findings into effective therapeutic strategies that enhance the quality of care for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported